Salmonella Bloodstream Infection Secondary to Treatment with Baricitinib in COVID-19

Isr Med Assoc J. 2023 Jan;25(1):78.

Authors

Shoshana Amos¹, Hila Elinav², Elchanan Parnasa¹

Affiliations

¹ Department of Internal Medicine, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel.
² Departments of Clinical Microbiology and Infectious Diseases, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel.

PMID: 36718747

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19 Drug Treatment
COVID-19*
Humans
Salmonella
Sepsis*

Substances

baricitinib